BRANDES INVESTMENT PARTNERS, LP – Eagle Pharmaceuticals, Inc. Transaction History
BRANDES INVESTMENT PARTNERS, LP portfolio value:
$12.36M
portfolio value
BRANDES INVESTMENT PARTNERS, LP quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.77% | 3.56K shares | -8.26M | $26.42 | 467.85K |
| Q2 2022 | share | Increase | +7.51% | 32.44K shares | -744K | $44.43 | 464.29K |
| Q1 2022 | share | Decrease | -29.71% | -182.51K shares | -9.91M | $49.49 | 431.85K |
| Q4 2021 | share | Decrease | -8.72% | -58.71K shares | -6.26M | $51.1 | 614.36K |
| Q3 2021 | share | Decrease | -6.11% | -43.79K shares | 6.86M | $55.78 | 673.07K |
| Q2 2021 | share | Increase | +46.41% | 227.24K shares | 10.57M | $42.8 | 716.87K |
| Q1 2021 | share | Increase | +85.19% | 225.23K shares | 7.80M | $41.74 | 489.62K |
| Q4 2020 | share | Increase | +70.66% | 109.47K shares | 5.71M | $46.57 | 264.39K |
| Q3 2020 | share | Increase | +2084.80% | 147.83K shares | 6.24M | $42.48 | 154.92K |
| Q2 2020 | share | Decrease | -95.29% | -143.51K shares | -6.58M | $47.98 | 7.09K |
| Q1 2020 | share | Increase | +2802.87% | 145.41K shares | 6.61M | $46 | 150.60K |
| Q4 2019 | share | Increase | +1.11% | 57 shares | 22K | $60.08 | 5.18K |
| Q3 2019 | share | Decrease | -30.60% | -2.26K shares | -122K | $56.57 | 5.13K |
| Q2 2019 | share | Decrease | -66.36% | -14.58K shares | -698K | $55.68 | 7.39K |
| Q1 2019 | share | Increase | +3.13% | 668 shares | 252K | $50.49 | 21.97K |
| Q4 2018 | share | Increase | +482.56% | 17.65K shares | 604K | $40.29 | 21.31K |
| Q3 2018 | share | Decrease | -69.48% | -8.32K shares | -653K | $69.33 | 3.65K |
| Q2 2018 | share | Decrease | -52.48% | -13.23K shares | -421K | $75.66 | 11.98K |
| Q1 2018 | share | Increase | 0.00% | 25.21K shares | 1.32M | $52.69 | 25.21K |